Autoimmune Diseases

Coeliac Disease (CD)

Publishing date
06 Jun 2014
Submission deadline
17 Jan 2014

Lead Editor

1Department of Paediatrics, Sapienza University of Rome, Rome, Italy

2Section of Pediatric Gastroenterology, University of Chicago, Chicago, IL, USA

3University of Medicine and Pharmacy “Carol Davila”, Bucharest,Romania

4Tampere Center for Child Health Research, University of Tampere, School of Medicine, Tampere, Finland

Coeliac Disease (CD)


Coeliac disease (CD) is an autoimmune disorder, caused by a permanent intolerance to gluten contained in wheat and to similar prolamines present in barley and rye. It is a common disease, as its prevalence, in Caucasian populations, is about 1%. There are several patterns of clinical presentation: symptomatic CD and silent CD, both characterized by typical histological lesions in the small bowel mucosa, as well as latent and potential CD, where by definition the small bowel mucosa is not damaged. Nowadays the gluten-free diet for life is the only therapy available for CD. Considerable progresses have been made regarding the field of biotechnology, which led to a better understanding of the genetic mechanisms involved in CD and the identification of new pathogenetic pathways that could be targeted by new drugs. We invite authors to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the molecular and genetic pathophysiology of CD. We are particularly interested in articles that explore advances in molecular genetics and molecular diagnostics; clinical characterization of CD; current concepts in the treatment of CD and new possible drugs therapy. Potential topics include, but are not limited to:

  • Elucidating the role of genetic and environmental factors in the development of CD
  • Identification of new pathogenetic pathways that could be targeted by new drugs
  • Clinical patterns of CD and related diseases
  • New possible strategies in the diagnosis of CD
  • Development and testing of novel and effective therapies

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:


  • Special Issue
  • - Volume 2014
  • - Article ID 623784
  • - Editorial

Coeliac Disease

Raffaella Nenna | Stefano Guandalini | ... | Kalle Kurppa
  • Special Issue
  • - Volume 2014
  • - Article ID 623514
  • - Clinical Study

Celiac Disease in Adult Patients: Specific Autoantibodies in the Diagnosis, Monitoring, and Screening

Evagelia Trigoni | Alexandra Tsirogianni | ... | Chryssa Papasteriades
  • Special Issue
  • - Volume 2014
  • - Article ID 237107
  • - Research Article

Anti-Transglutaminase 6 Antibodies in Children and Young Adults with Cerebral Palsy

Reidun Stenberg | Marios Hadjivassiliou | ... | Daniel Aeschlimann
  • Special Issue
  • - Volume 2014
  • - Article ID 927190
  • - Research Article

Exploring T Cell Reactivity to Gliadin in Young Children with Newly Diagnosed Celiac Disease

Edwin Liu | Kristen McDaniel | ... | Aaron W. Michels
  • Special Issue
  • - Volume 2014
  • - Article ID 756138
  • - Review Article

A Metabolomic Perspective on Coeliac Disease

Antonio Calabrò | Ewa Gralka | ... | Leonardo Tenori
  • Special Issue
  • - Volume 2014
  • - Article ID 417356
  • - Research Article

Prevalence of Thyroid Autoimmunity in Children with Celiac Disease Compared to Healthy 12-Year Olds

Maria van der Pals | Anneli Ivarsson | ... | Annelie Carlsson
  • Special Issue
  • - Volume 2013
  • - Article ID 389590
  • - Research Article

Oral Signs and HLA-DQB1*02 Haplotypes in the Celiac Paediatric Patient: A Preliminary Study

M. Erriu | G. M. Abbate | ... | L. Levrini
Autoimmune Diseases
 Journal metrics
See full report
Acceptance rate-
Submission to final decision-
Acceptance to publication-
Journal Citation Indicator0.400
Impact Factor-

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.